It's unlikely imo.
You could see an increase if they decide to classify peptides (or more of them to be precise) as Controlled substances. The price from China would probably stay the same, but ordering would have additional risk and domestic prices would increase.
If usage keeps increasing like it is right now, I'm unsure if the best labs would be able to keep up with production (or raw production), so that could create a price hike for quality stuff - But I find that unlikely too.
One thing is for sure, availability will be high, and I don't think there will be any significant changes in pricing - But that's just my guess